GSK Spends $903 Million For 72.5% Stake In India Consumer Subsidiary
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline has bought a majority stake in its India unit, GlaxoSmithKline Consumer Healthcare, paying $903 million to bring its stake from 43.2% to 72.5%.